Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Warmuth Markus sold 8,000 Monte Rosa Therapeutics, Inc. shares (Form 4)

Traded Apr 14, 2026 · Filed Apr 15, 2026

On Apr 14, 2026, Warmuth Markus (Director, President & CEO) sold 8,000 Monte Rosa Therapeutics, Inc. shares at US$17.64 for US$141K, leaving 605,471 shares. Filed Apr 15, 2026 (Form 4).

Sold
8,000 shares
Price
US$17.64
Value
US$141K
Holding after
605,471 shares
Trading plan
No
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 14, 2026Common StockSale8,000US$17.64605,471Direct

Source

View original at SEC

Related